Approximately 25% of pediatric B-cell precursor ALL (BCP-ALL) patients carry the t(12;21)(p13;q22) translocation, which fuses the N-terminal part of the ETS variant 6 (ETV6) with virtually the entire Runt-related transcription factor 1 (RUNX1). Here, RUNX1 is linked to acute lymphoblastic leukemia.